Novel insights into the potential involvement of 5-HT7receptors in endocrine dysregulation in stress-related disorders

Reviews in the Neurosciences

Volumn 25, Issue 3, 2014, Pages 439-449

  Terrón, José A ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

5 HT7receptors; Chronic stress; Corticosteroids; HPA axis dysregulation; Stress related disorders

Indexed keywords

3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; CORTICOSTEROID; CORTICOTROPIN; GLUCOCORTICOID; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SB 656104; SEROTONIN 7 RECEPTOR; SEROTONIN ANTAGONIST; UNCLASSIFIED DRUG; SEROTONIN RECEPTOR; SEROTONIN RECEPTOR AFFECTING AGENT;

ADRENAL CORTEX ADENOMA; CHRONIC STRESS; CORTICOSTEROID RELEASE; DEPRESSION; ENDOCRINE DISEASE; HORMONE ACTION; HORMONE RELEASE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR DEPRESSION; MOOD DISORDER; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REVIEW; SEROTONINERGIC SYSTEM; ANIMAL; ARTICLE; BEHAVIOR; DRUG EFFECT; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM;

ANIMALS; BEHAVIORAL SYMPTOMS; ENDOCRINE SYSTEM DISEASES; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; RECEPTORS, SEROTONIN; SEROTONIN AGENTS;

EID: 84907169990     PISSN: 03341763     EISSN: 21910200     Source Type: Journal    
DOI: 10.1515/revneuro-2014-0017     Document Type: Review

References (106)

1. Armario A. Lopez-Calderon A. Jolin T. and Balasch J. (1986). Response of anterior pituitary hormones to chronic stress. The specificity of adaptation. Neurosci. Biobehav. Rev. 10 245-250
2. Azmitia E.C. (2001). Modern views on an ancient chemical: serotonin effects on cell proliferation maturation and apoptosis. Brain Res. Bull. 56 413-424
3. Bagdy G. and Kalogeras K.T. (1993). Stimulation of 5-HT1A and 5-HT2/5-HT1C receptors induce oxytocin release in the male rat. Brain Res. 611 330-332
4. Bambico F.R. Nguyen N.T. and Gobbi G. (2009). Decl ine in serotonergic firing activity and desensitization of 5-HT1A autoreceptors after chronic unpredictable stress. Eur. Neuropsychopharmacol. 19 215-228
5. Bard J.A. Zgombick J. Adham N. Vaysse P. Branchek T.A. and Weinshank R.L. (1993). Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. J. Biol. Chem. 268 23422-23426.
6. Barnum C.J.,Blandino P. Jr.,Deak T., 2007, Adaptation in the corticosterone and hyperthermic responses to stress following repeated stressor exposure, J. Neuroendocrinol., 19, 632-642
7. Bhatnagar S. Huber R. Nowak N. and Trotter P. (2002). Lesions of the posterior paraventricular thalamus block habituation of hypothalamic-pituitary-adrenal responses to repeated restraint. J. Neuroendocrinol. 14 403-410
8. Blier P. Haddjeri N. Szabo S.T. and Dong J. (2001). Enhancement of serotoninergic function-A sometimes insufficient cause of antidepressant action. Hum. Psychopharmacol. 16 23-27
9. Bonaventure P. Nepomuceno D. Hein L. Sutcliffe J.G. Lovenberg T. and Hedlund P.B. (2004). Radioligand binding analysis of knockout mice reveals 5-hydroxytryptamine7 receptor distribution and uncovers 8-hydroxy-2-(di-n-propylamino) tetralin interaction with α2 adrener gic receptors. Neuroscience 124 901-911
10. Bonaventure P. Kelly L. Aluisio L. Shelton J. Lord B. Galici R. Miller K. Atack J. Lovenberg T.W. and Dugovic C. (2007). Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission antidepressant-like behavior and rapid eye movement sleep suppression induced by citalopram in rodents. J. Pharmacol. Exp. Ther. 321 690-698
11. Bornstein S.R. Engeland W.C. Ehrhart-Bornstein M. and Herman J.P. (2008). Dissociation of ACTH and glucocorticoids. Trends Endocrinol. Metab. 19 175-180
12. Brady L.S. Whitfield H.J. Jr. Fox R.J. Gold P.W. and Herkenham M. (1991). Long-term antidepressant administration alters corticotropin-releasing hormone tyrosine hydroxylase and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications. J. Clin. Invest. 87 831-837
13. Brady L.S. Gold P.W. Herkenham M. Lynn A.B. and Whitfield H.J. Jr. (1992). The antidepressants fluoxetine idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications. Brain Res. 572 117-125
14. Chabre O. Liakos P. Vivier J. Chaffanjon P. Labat-Moleur F. Martinie M. Bottari S.P. Bachelot I. Chambaz E.M. Defaye G. and Feige J.J. (1998). Cushing's syndrome due to a gastric inhibitory polypeptide-dependent adrenal adenoma: insights into hormonal control of adrenocort ical tumorigenesis. J. Clin. Endocrinol. Metab. 83 3134-3143
15. Charmandari E. Tsigos C. and Chrousos G. (2005). Endocrinology of the stress response. Annu. Rev. Physiol. 67 259-284
16. Chen J. Young S. Subburaju S. Sheppard J. Kiss A. Atkinson H. Wood S. Lightman S. Serradeil-Le Gal C. and Aguilera G. (2008). Vasopressin does not mediate hypersensitivity of the hypothal amic pituitary adrenal axis during chronic stress. Ann. N.Y. Acad. Sci. 1148 349-359
17. Chrousos G.P. (2009). Stress and disorders of the stress system. Nat. Rev. Endocrinol. 5 374-381
18. Chrousos G.P. and Gold P.W. (1992). The concepts of stress and stress system disorders: overview of physical and behavioral homeostasis. J. Am. Med. Assoc. 267 1244-1252
19. Chrousos G.P. and Kino T. ( 2007). Glucocorticoid action networks and complex psychiatric and/or somatic disorders. Stress 10 213-219
20. Clemett D.A. Cockett M.I. Marsden C.A. and Fone K.C. (1998). Antisense oligonu cleotide-induced reduction in 5-hydroxytryptamine 7 receptors in the rat hypothalamus without alteration in exploratory behaviour or neuroendocrine function. J. Neurochem. 71 1271-1279
21. Contesse V. Lenglet S. G rumolato L. Anouar Y. Lihrmann I. Lefebvre H. Delarue C. and Vaudry H. (1999). Pharmacological and molecular characterization of 5-hydroxytryptamine7 receptors in the rat adrenal gland. Mol. Pharmacol. 56 552-561
22. Contesse V. Reznik Y. Louiset E. Duparc C. Cartier D. Sicard F. Laquerriere A. Parmentier F. Kuhn J.M. Vaudry H. et al. (2005). Abnormal sensitivity of cortisol -producing adrenocortical adenomas to serotonin: in vivo and in vitro studies. J. Clin. Endocrinol. Metab. 90 2843-2850
23. Czyrak A. Maćkowiak M. Chocyk A. Fijać K. Tokarski K. Bijak M. and Wedzony K. (2002). Prolonged corticosterone treatment alters the responsiveness of 5-HT1A receptors to 8-OH-DPAT in rat CA1 hippocampal neurons. Naunyn-Schmiedebergs Arch. Pharmacol. 366 357-367
24. Dal-Zotto S. Martí O. and Armario A. (2000). Influence of single or repeated experience of rats with forced swimming on behavioural and physiological responses to the stressor. Behav. Brain Res. 114 175-181
25. De Boer S.F. Koopmans S.J. Slangen J.L. and Van der Gugten J. (1990). Plasma catecholamine corticosterone and glucose responses to repeated stress in rats: effect of interstressor interval length. Physiol. Behav. 47 1117-1124
26. Figueiredo H.F. Bodie B.L. Tauchi M. Dolgas C.M. and Herman J.P. (2003). Stress integration after acute and chronic predator stress: differential activation of central stress circuitry and sensitizati on of the hypothalamo-pituitary-adrenocortical axis. Endocrinology 144 5249-5258
27. Forbes I.T. Douglas S. Gribble A.D. Ife R.J. Lightfoot A.P. Garner A.E. Riley G.J. Jeffrey P. Stevens A.J. Stean T.O. et al. (2002). SB-656104-A: a novel 5-HT7 receptor antagonist with improved in vivo properties. Bioorg. Med. Chem. Lett. 12 3341-3344.
28. Fragoso M.C.,Domenico S.,Latronico A.C.,Martin R.M.,Pereira M.A.,Zerbini M.C.,Lucon A.M.,Mendonca B.B., 2003, Cushing's syndrome secondary to adrenocorticotropinindependent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene, J. Clin. Endocrinol. Metab., 88, 2147-2151
29. Garcí a A. Martí O. Vallés A. Dal-Zotto S. and Armario A. (2000). Recovery of the hypothalamic-pituitary-adrenal response to stress. Ef fect of stress intensity stress duration and previous stress exposure. Neuroendocrinology 72 114-125
30. Garcí a-Iglesias B.B. Mendoza-Garrido M.E. Gutiérrez-Ospina G. Rangel-Barajas C. Noyola-Díaz M. and Terró n J.A. (2013). Sensitization of restraint-induced corticosterone secretion after chronic restraint in rats: involvement of 5-HT7 receptors. Neuropharmacology 71 216-227
31. Girotti M. Pace T.W. Gay lord R.I. Rubin B.A. Herman J.P. and Spencer R.L. (2006). Habituation to repeated restraint stress is associated with lack of stress-induced c-fos expression in primary sensory processing areas of the rat brain. Neuroscienc e 138 1067-1081
32. Gold P.W. Loriaux D.L. Roy A. Kling M.A. Calabrese J.R. Kellner C.H. Nieman L.K. Post R.M. Pickar D. Gallucci W. et al. (1986). Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. N. Engl. J. Med. 314 1329-1335
33. Gold P.W. Licinio J. Wong M.L. and Chrousos G.P. (1995). Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs. Ann. NY Acad. Sci. 771 716-729
34. Graeff F.G. Guimarães F.S. De Andrade T.G. and Deakin J.F. (1996). Role of 5-HT in stress anxiety and depression. Pharmacol. Biochem. Behav. 54 129-141
35. Gray M. Bingham B. and Viau V. (20 10). A comparison of two repeated restraint stress paradigms on hypothalamicpituitary-adrenal axis habituation gonadal status and central neuropeptide expression in adult male rats. J. Neuroendocrinol. 22 92-101
36. Guscott M. Bristow L.J. Hadingham K. Rosahl T.W. Beer M.S. Stanton J.A. Bromidge F. Owens A.P. Huscroft I. Myers J. et al. (2005). Genetic knockout and pharmacological blockade studies of the 5-HT7 r eceptor suggest therapeutic potential in depression. Neuropharmacology 48 492-502
37. Hanley N.R. and Van de Kar L.D. (2003). Serotonin and the neuroendocrine regulation of the hypothalamic-pituitaryadrenal axis in health and disease. Vitam. Horm. 66 189-255
38. Hannon J. and Hoyer D. (2008). Molecular biology of 5-HT receptors. Behav. Brain Res. 195 198-213
39. Harris R.B. Gu H. Mitch ell T.D. Endale L. Russo M. and Ryan D.H. (2004). Increased glucocorticoid response to a novel stress in rats that have been restrained. Physiol. Behav. 81 557-568
40. Hedlund P.B. (2009). The 5-HT7 receptor and disorders of the nervous system: an overview. Psychopharmacology (Berl) 206 345-354
41. Hedlund P.B. Huitron-Resendiz S. Henriksen S.J. and Sutcliffe J.G. (2005). 5-HT7 receptor inhibition and inactivation induce antidepressant-like behavior and sleep pattern. Biol. Psychiatry 58 831-837
42. Heidmann D.E.A. Metcalf M.A. Kohen R. and Hamblin M.W. (1997). Four 5-hydroxytryp tamine7 (5-HT7) receptor isoforms in human and rat produced by alternative splicing: species differences due to altered intron-exon organization. J. Neurochem. 68 1372-1381
43. Holmes M.C. Di R.G. Beckford U. Gillham B. and Jones M.T. (1982). Role of serotonin in the control of secretion of corticotrophin releasing factor. J. Endocrinol. 93 151-160
44. Holsboer F. and Barden N. (1996). Antidepressa nts and hypothalamic-pituitary adrenocortical regulation. Endocr. Rev. 17 187-205
45. Holsboer F. Lauer C.J. Schreiber W. and Krieg J.C. (1995). Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuroendocrinology 62 340-347
46. Inder W.J. Prickett T.C. Mulder R.T. Donald R.A. and Joyce P.R. (2001). Reduction in basal afternoon plasma ACTH during early treatment of depression with fluoxetine. Psychopharmacology (Berl) 156 73-78
47. Joë ls M. Verkuyl J.M. and Van Riel E. (2003). Hippocampal and hypothalamic function after chronic stress. Ann. NY Acad. Sci. 1007 367-378
48. Jones M.T. Hillhouse E.W. and Burden J. (1976). Effect on various putative neurotransmitters on the secretion of corticotrophinreleasing hormone from the rat hypothalamus in vitro-A model of the neurotransmitters involved. J. Endocrinol. 69 1-10.
49. Jorgensen H.,Knigge U.,Kjaer A.,Warberg J., 1999, Adrenocorticotropic hormone secretion in rats induced by stimulation with serotonergic compounds, J. Neuroendocrinol., 11, 283-290
50. Jorgensen H. Knigge U. Kjaer A. Moller M. and Warberg J. (2002). Serotonergic stimulation of corticotropin-releasing hormone and pro-opiomelanocortin gene expression. J. Neuroendocrinol. 14 788-795
51. Ju G. Duan X.J. and Zhang X. (1988). Serotonin-like immunore active fibers in the medial dorsal accessory group and the anterior fornical nucleus of the magnocellular neurosecretory system in the rat. Neurosci. Lett. 93 19-22
52. Keeney A. Jessop D.S. Harbuz M.S. Marsden C.A. Hogg S. and Blackburn-Munro R.E. (2006). Differential effects of acute and chronic social defeat stress on hypothalamic-pituitary-adrenal axis function and hippocampal serotonin release in mice. J. Neuroendocrinol. 18 330-338
53. Kageyama K. Tozawa F. Horiba N. Watanobe H. and Suda T. (1998). Serotonin stimulates corticotropin-releasing factor gene expression in the hypothalamic paraventricular nucleus of conscious ra ts. Neurosci. Lett. 243 17-20
54. Lacroix A. Baldacchino H. Bourdeau I. Hamet P. and Tremblay J. (2004). Cushing's syndrome variants secondary to aberrant hormone receptors. Trends Endocrinol. Metab. 15 375-382
55. Laplante P. Diorio J. and Meaney M.J. (2002). Serotonin regulates hippocampal glucocorticoid receptor expression via a 5-HT7 receptor. Brain Res. Dev. Brain Res. 139 199-203
56. Larsen P.J. Hay-Schmidt A. Vrang N. and Mikke lsen J.D. (1996). Origin of projections from the midbrain raphe nuclei to the hypothalamic paraventricular nucleus in the rat: a combined retrograde and anterograde tracing study. Neuroscience 70 963-988
57. Le Corr e S. Sharp T. Young A.H. and Harrison P.J. (1997). Increase of 5-HT7 (serotonin-7) and 5-HT1A (serotonin-1A) receptor mRNA expression in rat hippocampus after adrenalectomy. Psychopharmacology (Berl) 130 368-374
58. Li Y.C. Wang F.M. Pan Y. Qiang L.Q. Cheng G. Zhang W.Y. and Kong L.D. (2009). Antidepressant-like effects of curcumin on serotonergic receptor-coupled AC-cAMP pathway in chronic unpredictable mild stress of rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 33 435-449
59. Liposits Z. Phelix C. and Paull W.K. (1987). Synaptic interaction of serotonergic axons and corticotropin releasing factor (CR F) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. A light and electron microscopic immunocytochemical study. Histochemistry 86 541-549
60. Ló pez J.F. Vázquez D.M. Chalmers D.T. and Watson S.J. (1997). Regulation of 5-HT receptors and the hypothalamic-pituitaryadrenal axis. Implications for the neurobiology of suicide. Ann. NY Acad. Sci. 836 106-134
61. Louiset E. Contesse V. Grouss in L. Cartier D. Duparc C. Barrande G. Bertherat J. Vaudry H. and Lefebvre H. (2006). Expression of serotonin7 receptor and coupling of ectopic receptors to protein kinase A and ionic currents in adrenocorticot ropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome. J. Clin. Endocrinol. Metab. 91 4578-4586
62. Lovenberg T.W. Baron B.M. De Lecea L. Miller J.D. Prosser R.A. Rea M.A. Foye P.E. Racke M. Slone A.L. Siegel B.W. et al. (1993). A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms. Neuron 11 449-458
63. Ma X.M. and Lightman S.L. (1998). The arginine vasopressin and corticotrophin-releasing hormone gene transcription responses to varied frequencies of repeated stress in rats. J. Physiol. 510 605-614
64. Ma X.M. Lightman S.L. and Aguilera G. (1999). Vasopressin and corticotropin-releasing hormone gene responses to novel stress in rats adapted to repeated restraint. Endocrinology 140 3623-3632
65. M cEwen B.S. (2007). Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev. 87 873-904
66. McKittrick C.R. Blanchard D.C. Blanchard R.J. McEwen B.S. and Sakai R.R. (1995). Serotonin receptor binding in a colony model of chronic social stress. Biol. Psychiatry 37 383-393
67. Mizoguchi K. Shoji H. Ikeda R. Tanaka Y. and Tabira T. (2008). P ersistent depressive state after chronic stress in rats is accompanied by HPA axis dysregulation and reduced prefrontal dopaminergic neurotransmission. Pharmacol. Biochem. Behav. 91 170-175
68. Mnie-Filali O. Faure C. Lambás-Señas L. El Mansari M. Belblidia H. Gondard E. Etié vant A. Scarna H. Didier A. Berod A. et al. (2011). Pharmacological blockade of 5-HT7 receptors as a putative fast acting antidepressant strategy . Neuropsychopharmacology 36 1275-1288
69. Mullins U.L. Gianutsos G. Eison A.S. (1999). Effects of antidepressants on 5-HT7 receptor regulation in the rat hypothalamus. Neuropsychopharmacology 21 352-367.
70. Muneoka K.T.,Takigawa M., 2003, 5-Hydroxytryptamine7 (5-HT7) receptor immunoreactivity-positive ?stigmoid body'-like structure in developing rat brains. Int. J. Dev. Neurosci., 21, 133-143.
71. Neumaier J.F. Sexton T.J. Yracheta J. Diaz A.M. and Brownfield M. (2001). Localization of 5-HT7 receptors in rat brain by immunocytochemistry in situ hybridization and agonist stimulated cFos expression. J. Chem. Neuroanat. 21 63-73
72. Orr T.E. Meyerhoff J.L. Mougey E.H. and Bunnell B.N. (1990). Hyperresponsiveness of the rat neuroendocrine system due to repeated exposure to stress. Psychoneuroendocrinology 15 317-328
73. Pan L. and Gilbert F. (1992). Activation of 5-HT1A receptor subtype in the paraventricular nuclei of the hypothalamus induces CRH and ACTH release in the rat. Neuroendocrinology 56 797-802
74. Pierce P.A. Xie G.X. Levine J.D. and Peroutka S.J. (1996). 5-Hydroxytryptamine receptor subtype messenger RNAs in rat peripheral sensory and sympathetic ganglia: a polymerase chain reaction study. Neuroscience 70 553-559
75. Pierce P.A. Xie G.X. Meuser T. and Peroutka S.J. (1997). 5-Hydroxytryptamine receptor subtype messenger RNAs in human dorsal root ganglia: a polymerase chain reaction study. Neuroscience 81 813-819
76. Pitman D.L. Ottenweller J.E. and Natelson B.H. (1990). Effect of stressor intensity on habituation and sensitization of glucocorticoid responses in rats. Behav. Neurosci. 104 28-36
77. Plassat J.L. Amlaiky N. and Hen R. (1993). Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase. Mol. Pharmacol. 44 229-236
78. Plotsky P. Owens M.J. and Nemeroff C.B. (1995). Neuropeptide alterations in affective disorders. Psychopharmacology: The Fourth Generation of Progress. F.E. Bloom and D.J. Kupfer eds. (Raven Press New York) pp. 971-981
79. Roth B.L. Craig o S.C. Choudhary M.S. Uluer A. Monsma F.J. Jr. Shen Y. Meltzer H.Y. and Sibley D.R. (1994). Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J. Pharmacol. Exp. Ther. 268 1403-1410
80. Roth B.L. Hanizavareh S.M. and Blum A.E. (2004). Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders. Psychopharmacology (Berl) 174 17-24
81. Ruat M. Traiffort E. Leurs R. Tardivel-Lacombe J. Diaz J. Arrang J.M. and Schwartz J.C. (1993). Molecular cloning characterizati on and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proc. Natl. Acad. Sci. USA 90 8547-8551
82. Sarkisyan G. Roberts A.J. and Hedlund P.B. (2010). The 5-HT7 receptor as a mediator and modulator of antidepressant-like behavior. Behav. Brain Res. 209 99-108
83. Sawchenko P.E. Swanson L.W. Steinbusch H.W. and Verhofstad A.A. (1983). The distribution and cells of origin of serotonergic inputs to the paraventricular and supraoptic nuclei of the rat. Brain Res. 277 355-360
84. Sawchenko P.E. Swanson L.W. and Vale W.W. (1984). Co-expression of corticotropin-releasing factor a nd vasopressin immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat. Proc. Natl. Acad. Sci. USA 81 1883-1887
85. Saydoff J.A. Carnes M. and Brownfield M.S. (1993). The role of serotonergic neurons in intravenous hypertonic saline-induced secretion of vasopressin oxytocin and ACTH. Brain Res. Bull. 32 567-572
86. Schwartz W.J. (1993). A clinician's primer on the circadian clock: its localization function and resetting. Adv. Int. Med. 38 81-106
87. Shen Y. Monsma F.J. Metcalf M.A. Jose P.A. Hamblin M.W. and Sibley D.R. (1993). Molecular cloning and expression of a 5-hydroxytrypt amine7 serotonin receptor subtype. J. Biol. Chem. 268 18200-18204
88. Shimizu M. Nishida A. Zensho H. Miyata M. and Yamawaki S. (1997). Down-regulation of 5-hydroxytryptamine7 receptors by dexamethasone in rat frontocortical astrocytes. J. Neurochem. 68 2604-2609
89. Sleight A.J. Carolo C. Petit N. Zwingelstein C. and Bourson A. (1995). Identification of 5-hydroxyt ryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment. Mol. Pharmacol. 47 99-103
90. Stamp J.A. and Herbert J. (1999). Multiple immediate-early gene expression during physiological and endocrine adaptation to repeated stress. Neuroscience 94 1313-1322
91. Swanson L.W. Sawchenko P.E. Rivier J. and Vale W.W. (1983). Organization of ovine corticotropin-releasing f actor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36 165-186.
92. Swords F.M.,Baig A.,Malchoff D.M.,Malchoff C.D.,Thorner M.O.,King P.J.,Hunyady L.,Clark A.J.L., 2002, Impaired desensitization of a mutant adrenocorticotropin receptor associated with apparent constitutive activity. Mol. Endocrinol., 16, 2746-2753
93. Thomson F. and Craighea d M. (2008). Innovative approaches for the treatment of depression: targeting the HPA axis. Neurochem. Res. 33 691-707
94. Tokarski K. Pitra P. Duszynska B. and Hess G. (2009). Imipramine counteracts corticosterone-induced alterations in the effects of the activation of 5-HT7 receptors in rat hippocampus. J. Physiol. Pharmacol. 60 83-88
95. Tsou A.P. Kosaka A. Bach C. Zuppan P. Yee C. Tom L. Alvarez R. Ramsey S. Bonhaus D.W. Stefanich E. et al. (1994). Cloning and expression of a 5-hydroxytryptamine7 receptor positively coupled to adenylyl cyclase. J. Neurochem. 63 456-464
96. Ulrich-Lai Y.M. Figueiredo H.F. Ostrander M.M. Choi D.C. Engeland W.C. and Herman J.P. (2006). Chronic stress induces adrenal hyperplasia and hypertrophy in a subregionspecific manner. Am. J. Physiol. Endocrino l. Metab. 291 E965-E973
97. Van de Kar L.D. (1991). Neuroendocrine pharmacology of serotonergic (5-HT) neurons. Annu. Rev. Pharmacol. Toxicol. 31 289-320
98. Varnas K. Thomas D.R. Tu pala E. Tiihonen J. and Hall H. (2004). Distribution of 5-HT7 receptors in the human brain: a preliminary autoradiographic study using [3H]SB-269970. Neurosci. Lett. 367 313-316
99. Vicentic A. Li Q. Battaglia G. and Van de Kar L.D. (1998). WAY-100635 inhibits 8-OH-DPAT-stimulated oxytocin ACTH and corticosterone but not prolactin secretion. Eur. J. Pharmacol. 346 261-266
100. Wesołowska A. and Kowalska M. (2008). Influence of serotonin 5-HT7 receptor blockade on the behavioral and neurochemical effects of imipramine in rats. Pharmacol Rep 60 464-474
101. Wesołowska A. Nikiforuk A. and Stachowicz K. (2006 a ). Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats. Eur. J. Pharmacol. 553 185-190
102. Wesołowska A. Nikiforuk A. Stachowicz K. and Tatarczynska E. (2006b ). Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression. Neuropharmacology 51 578-586
103. Wesołowska A. Tatarczyńska E. Nikiforuk A. and Chojnacka-Wójcik E. (2007). Enhancement of the anti-immobility action of antidepressants by a selective 5-HT7 receptor antagonist in the forc ed swimming test in mice. Eur. J. Pharmacol. 555 43-47
104. Williams G.V. Rao S.G. and Goldman-Rakic P.S. (2002). The physiological role of 5-HT2A receptors in working memory. J. Neurosci. 22 2843-2854
105. Yau J.L. Noble J. Widdowson J. and Seckl J.R. (1997). Impact of adrenalectomy on 5-HT6 and 5-HT7 receptor gene expression in the rat hippocampus. Mol. Brain Res. 45 182-186
106. Yau J.L. Noble J. and Seckl J.R. (2001). Acute restraint stress increases 5-HT7 receptor mRNA expression in the rat hippocampus. Neurosci. Lett. 309 141-144